Epstein–Barr virus (EBV) provides survival factors to EBV+ diffuse large B‐cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+ DLBCL

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Immunology

• Publication date

  2017-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/imm.12792PMID 28699226PMCID PMC5680075
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers

  2018cited by this paper
• The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

  2016cited by this paper
• Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma

  2015cited by this paper
• CXCR4 expression enhances diffuse large B cell lymphoma dissemination and decreases patient survival

  2015cited by this paper
• Effect of interleukin 21 and its receptor on CD8+ T cells in the pathogenesis of diffuse large B-cell lymphoma

  2014cited by this paper
• The tumour microenvironment in B cell lymphomas

  2014cited by this paper
• Functional Interleukin-21 Polymorphism Is a Protective Factor of Diffuse Large B-Cell Lymphoma

  2014cited by this paper
• The World Health Organization Classification of Lymphoid Neoplasms

  2013cited by this paper
• Chemokine receptors in gastric MALT lymphoma: loss of CXCR4 and upregulation of CXCR7 is associated with progression to diffuse large B-cell lymphoma

  2013cited by this paper
• EBV counteracts IL‐21‐induced apoptosis in an EBV‐positive diffuse large B‐cell lymphoma cell line

  2013cited by this paper
• Exploiting synthetic lethality for the therapy of ABC diffuse large B cell lymphoma.

  2012cited by this paper
• Epstein-Barr virus microRNAs repress BCL6 expression in diffuse large B-cell lymphoma

  2012cited by this paper
• Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas

  2012cited by this paper
• Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

  2011cited by this paper
• Roscovitine Inhibits EBNA1 Serine 393 Phosphorylation, Nuclear Localization, Transcription, and Episome Maintenance

  2011cited by this paper
• Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

  2011cited by this paper
• Epstein-Barr Virus-positive Diffuse Large B-cell Lymphomas of the Elderly

  2011cited by this paper
• BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.

  2010cited by this paper
• Novel IL-21 signaling pathway up-regulates c-Myc and induces apoptosis of diffuse large B-cell lymphomas.

  2010cited by this paper
• Chemokines and chemokine receptors: new insights into cancer-related inflammation.

  2010cited by this paper
• IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

  2009cited by this paper
• BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma

  2009cited by this paper
• Epstein-Barr Virus-Encoded Bcl-2 Homologue Functions as a Survival Factor in Wp-Restricted Burkitt Lymphoma Cell Line P3HR-1

  2009cited by this paper
• Diffuse large B-cell lymphoma--more than a diffuse collection of large B cells: an entity in search of a meaningful classification.

  2009cited by this paper
• Epstein-Barr virus positive diffuse large B-cell lymphoma of the elderly

  2009cited by this paper
• Identification of a chemokine receptor profile characteristic for mediastinal large B‐cell lymphoma

  2009cited by this paper
• Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature.

  2009cited by this paper
• Changes in chemokines and chemokine receptor expression on tonsillar B cells upon Epstein–Barr virus infection

  2009cited by this paper
• The role of IL‐21 in regulating B‐cell function in health and disease

  2008cited by this paper
• Activation-dependent induction of Blimp-1.

  2008cited by this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from May to July 2008

  2008cited by this paper
• The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.

  2007cited by this paper
• Epstein–Barr virus infection in humans: from harmless to life endangering virus–lymphocyte interactions

  2007cited by this paper
• IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells.

  2007cited by this paper
• Epstein–Barr virus infection negatively impacts the CXCR4‐dependent migration of tonsillar B cells

  2006cited by this paper
• IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines.

  2006cited by this paper
• Pyothorax-associated lymphoma.

  2006cited by this paper
• EBNA2 Interferes with the Germinal Center Phenotype by Downregulating BCL6 and TCL1 in Non-Hodgkin's Lymphoma Cells

  2006cited by this paper
• Loss of expression of Epstein‐Barr virus nuclear antigen‐2 correlates with a poor prognosis in cases of pyothorax‐associated lymphoma

  2006cited by this paper
• [Therapeutic inhibition of Epstein-Barr virus-associated tumor cell growth by dominant-negative EBNA1].

  2005cited by this paper
• Terminal Differentiation into Plasma Cells Initiates the Replicative Cycle of Epstein-Barr Virus In Vivo

  2005cited by this paper
• Dominant-negative EBNA1によるEBウイルス腫瘍の抑制

  2005cited by this paper
• Eradication of Epstein-Barr virus episome and associated inhibition of infected tumor cell growth by adenovirus vector-mediated transduction of dominant-negative EBNA1.

  2005cited by this paper
• In vitro EBV‐infected subline of KMH2, derived from Hodgkin lymphoma, expresses only EBNA‐1, while CD40 ligand and IL‐4 induce LMP‐1 but not EBNA‐2

  2005cited by this paper
• Role of Chemokines in Angiogenesis: CXCL12/SDF‐1 and CXCR4 Interaction, a Key Regulator of Endothelial Cell Responses

  2003cited by this paper
• Epstein-Barr virus provides a survival factor to Burkitt's lymphomas

  2003cited by this paper
• Senile EBV+ B-Cell Lymphoproliferative Disorders: A Clinicopathologic Study of 22 Patients

  2003cited by this paper
• Expression of cyclin-dependent kinase inhibitor p27(Kip1) in AIDS-related diffuse large-cell lymphomas is associated with Epstein-Barr virus-encoded latent membrane protein 1.

  2002cited by this paper
• Human B Cells Immortalized with Epstein-Barr Virus Upregulate CCR6 and CCR10 and Downregulate CXCR4 and CXCR5

  2002cited by this paper
• CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma.

  2002cited by this paper
• The role of chemoattraction in cancer metastases.

  2001cited by this paper
• Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

  2000cited by this paper
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

  1997cited by this paper
• A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project

  1997cited by this paper
• Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

  1996cited by this paper
• Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.

  1995cited by this paper
• Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.

  1991cited by this paper
• A new non-Hodgkin's B-cell line (DoHH2) with a chromosomal translocation t(14;18)(q32;q21).

  1991cited by this paper
• [Health and disease].

  1989cited by this paper
• Expression of Epstein‐Barr virus‐encoded proteins in nasopharyngeal carcinoma

  1988cited by this paper

• CD30 protects EBV-positive diffuse large B-cell lymphoma cells against mitochondrial dysfunction through BNIP3-mediated mitophagy.

  2024cites this paper
• EBV dUTPase: A Novel Modulator of Inflammation and the Tumor Microenvironment in EBV-Associated Malignancies

  2023cites this paper
• EBV Reactivation and Lymphomagenesis: More Questions than Answers

  2023cites this paper
• Development of dynamical network biomarkers for regulation in Epstein-Barr virus positive peripheral T cell lymphoma unspecified type

  2022cites this paper
• Disparity analysis and prognostic value of pretreatment whole blood Epstein‐Barr virus DNA load and Epstein‐Barr encoding region status in lymphomas: A retrospective multicenter study in Huaihai Lymphoma Working Group

  2021cites this paper
• CCR7 in Blood Cancers – Review of Its Pathophysiological Roles and the Potential as a Therapeutic Target

  2021cites this paper
• Cyclin-dependent Kinases as Emerging Targets for Developing Novel Antiviral Therapeutics.

  2021cites this paper
• Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: A retrospective single-center study

  2021cites this paper
• IL-21 Stimulates the expression and activation of cell cycle regulators and promotes cell proliferation in EBV-positive diffuse large B cell lymphoma

  2020cites this paper
• Clinical characteristics and outcomes for HIV-associated Diffuse Large B-cell Lymphoma in China: A retrospective single-center study

  2019cites this paper
• C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges

  2019cites this paper
• Epstein–Barr virus-positive diffuse large B-cell lymphoma features disrupted antigen capture/presentation and hijacked T-cell suppression

  2019cites this paper
• CCL19 and CCR7 Expression, Signaling Pathways, and Adjuvant Functions in Viral Infection and Prevention

  2019cites this paper
• EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers

  2018cites this paper
• New developments in the pathology of malignant lymphoma: a review of the literature published from May to August 2017

  2017cites this paper